These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8099376)

  • 21. A combination of CD34 selection and complement-mediated immunopurging (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells.
    Nimgaonkar M; Kemp A; Lancia J; Ball ED
    J Hematother; 1996 Feb; 5(1):39-48. PubMed ID: 8646480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunological treatment of human marrow in vitro in transplantation biology.
    Gribben JG; Nadler LM
    Cancer Treat Res; 1993; 64():189-211. PubMed ID: 8095793
    [No Abstract]   [Full Text] [Related]  

  • 23. Standardization of monoclonal antibodies for use in autologous bone marrow transplantation for common acute lymphoblastic leukemia.
    Bradstock KF; Favaloro EJ; Kabral A; Kerr A; Prendergast M; Berndt MC; Hughes WG; Zola H; Krishnan R; Haylock D
    Pathology; 1986 Apr; 18(2):197-205. PubMed ID: 2945154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
    Waddick KG; Uckun FM
    Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
    Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
    Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between multi-drug resistance and resistance to natural-killer-cell and lymphokine-activated killer-cell lysis in human leukemic cell lines.
    Treichel RS; Olken S
    Int J Cancer; 1992 Jan; 50(2):305-10. PubMed ID: 1370437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody.
    Alonso K; Medenica R; Morehead G
    Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations.
    Negrin RS; Pesando J
    J Clin Oncol; 1994 May; 12(5):1021-7. PubMed ID: 8164025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
    Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
    Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a monoclonal IgM antibody for purging of bone marrow for autologous transplantation.
    Zola H; Potter A; Neoh SH; Juttner CA; Haylock DN; Rice AM; Favaloro EJ; Kabral A; Bradstock KF
    Bone Marrow Transplant; 1987 Feb; 1(3):297-301. PubMed ID: 3332140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging.
    Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S
    Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894
    [No Abstract]   [Full Text] [Related]  

  • 32. Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow.
    Ball ED; Mills L; Hurd D; McMillan R; Gingrich R
    Prog Clin Biol Res; 1992; 377():97-110; discussion 111. PubMed ID: 1438450
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma.
    Gribben JG; Freedman AS; Neuberg D; Roy DC; Blake KW; Woo SD; Grossbard ML; Rabinowe SN; Coral F; Freeman GJ
    N Engl J Med; 1991 Nov; 325(22):1525-33. PubMed ID: 1944436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
    Schmidt-Wolf IG; Negrin RS; Kiem HP; Blume KG; Weissman IL
    J Exp Med; 1991 Jul; 174(1):139-49. PubMed ID: 1711560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.
    Hale G; Swirsky D; Waldmann H; Chan LC
    Br J Haematol; 1985 May; 60(1):41-8. PubMed ID: 3890929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of monoclonal antibodies and immune markers in the diagnosis, prognosis, and therapy of acute leukemia.
    Neame PB; Soamboonsrup P; Quigley JG; Pewarchuck W
    Transfus Med Rev; 1994 Jan; 8(1):59-75. PubMed ID: 8136608
    [No Abstract]   [Full Text] [Related]  

  • 37. Developments in purging in autotransplantation.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):687-715. PubMed ID: 8344886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of interleukin-2-stimulated lymphocytes and bispecific antibodies that efficiently lyse leukemic cells does not affect bone marrow CD34-positive stem cell function in vitro.
    Kaneko T; Fukuda J; Teramura M; Fusauchi Y; Kakui Y; Okumura K; Mizoguchi H; Oshimi K
    Bone Marrow Transplant; 1994 Aug; 14(2):213-7. PubMed ID: 7527685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
    Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J
    Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Model experiments for immunomagnetic elimination of leukemic cells from human bone marrow. Presentation of a novel magnetic separation system.
    Gruhn B; Häfer R; Müller A; Andrä W; Danan H; Zintl F
    Immunobiology; 1991 Nov; 183(5):374-85. PubMed ID: 1786986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.